Chiral -substituted -butyrolactones are known to beimportant intermediates for many biologically active compounds such as -aminobutyric acid (GABA) derivatives andlignans. We have developed a general, convenient, andscalable synthetic method for enantiomerically pure -substituted -butyrolactones, with either configuration, vianucleophilic cyclopropane ring opening of (1
S,5
R)- or(1
R,5
S)-bicyclic lactone followed by decarbethoxylation. Theutility of our method was demonstrated by streamlinedsynthesis of pregabalin ((
S)-3-isobutyl--aminobutyric acid),an anticonvulsant drug for the treatment of peripheralneuropathic pain.